Nanoparticle Biokinetics in Mice and Nonhuman Primates-Reference-Cited by-同舟云学术

Nanoparticle Biokinetics in Mice and Nonhuman Primates

Published:2017-09-18 Issue:9 Volume:11 Page:9514-9524
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Chiarelli Peter A.,Revia Richard A.,Stephen Zachary R.,Wang Kui,Jeon Mike,Nelson Veronica¹,Kievit Forrest M.,Sham Jonathan,Ellenbogen Richard G.,Kiem Hans-Peter¹,Zhang Miqin^ORCID

Affiliation:

1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, United States

Funder

National Cancer Institute

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.7b05377

Reference52 articles.

1. Brain cancer diagnosis and therapy with nanoplatforms☆

2. Animal models of disease: Pre-clinical animal models of cancer and their applications and utility in drug discovery

3. Delivering nanomedicine to solid tumors

4. Nanoparticle therapeutics: an emerging treatment modality for cancer

5. Current in vitro methods in nanoparticle risk assessment: Limitations and challenges

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Natural Binding Proteins in Therapy and Diagnostics;Life;2024-05-15

2. Simple thermal treatment to improve the MRI and magnetic hyperthermia performance of hybrid iron Oxide-Mesoporous silica nanocarriers;Journal of Molecular Liquids;2024-03

3. Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis;Chemical Science;2024

4. Pharmacokinetic, Pharmacodynamic, Preclinical and Clinical Models for Evaluation of Nanoparticles;Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications;2024

5. High-Performance T₁–T₂ Dual-Modal MRI Contrast Agents through Interface Engineering;ACS Applied Bio Materials;2023-05-25